The Society of Memorial Sloan-Kettering (MSK) held its 16th Annual Spring Ball on Thursday night, in the freshly redone ballroom of the Pierre Hotel, where 430 guests came out to support this ...
New leaders stepped into pivotal roles at MSK in 2025, bringing bold visions to advance clinical care, scientific research, immuno-oncology, and the emotional well-being of patients — collectively ...
SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center (MSK) have signed a memorandum of understanding (MoU) that will set in motion plans for the entities to combine their respective expertise to ...
Memorial Sloan Kettering Cancer Center and health insurer Anthem Blue Cross and Blue Shield have reached a deal on payment rates, maintaining coverage of cancer services for thousands of patients in ...
Tuesday morning, the nation’s largest insurance company, UnitedHealthcare and Memorial Sloan Kettering Cancer Center announced they had reached a multi-year agreement that will allow some 19,000 ...
Memorial Sloan Kettering Cancer Center is proud to announce the formation of MSK Ventures, a dedicated venture capital fund launching in 2026. MSK Ventures is designed to invest in high-conviction ...
Dr. Andrea Cercek holds Maya, daughter of Kelly Spill, a participant in MSK’s groundbreaking immunotherapy trial. The treatment allowed Kelly to avoid surgery and preserve her ability to have children ...
Post-election politics were very much in the air among guests at the Society of Memorial Sloan Kettering Cancer Center’s fall party Wednesday night at The Plaza hotel. During cocktails, the din was so ...